Sunshine Biopharma (SBFMW) Other Working Capital Changes (2010 - 2026)
Sunshine Biopharma (SBFMW) reported Other Working Capital Changes of -$154726.0 for Q1 2026, down 10.57% on a YoY basis from -$173019.5 in Q1 2025, and down 167.78% quarter-over-quarter from -$57782.0 in Q4 2025.
Sunshine Biopharma (SBFMW) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Sunshine Biopharma has reported Other Working Capital Changes for 17 years, with the latest figure at -$154726.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 10.57% year-over-year to -$154726.0; the trailing twelve-month figure through Mar 2026 stood at -$202318.0 (up 59.68% YoY), and the FY2025 full-year result was -$187523.0, down 190.52% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$154726.0, down from -$57782.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $568981.0 in Q1 2024, with the low at -$736637.0 in Q2 2024.
- Historically, Other Working Capital Changes has averaged -$11575.6 across 5 years, with a median of -$57782.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes tumbled 1860.45% — and 2024, when it jumped 538.19%.
- Sunshine Biopharma's Other Working Capital Changes stood at -$80611.0 in 2022, then jumped by 433.85% to $269120.0 in 2023, then jumped by 70.39% to $458558.0 in 2024, then tumbled by 112.6% to -$57782.0 in 2025, then tumbled by 167.78% to -$154726.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$154726.0 (Q1 2026), -$57782.0 (Q4 2025), and $125807.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -154,726.00 |
| Mar 31, 2026 | -154,726.00 |
| Dec 31, 2025 | -57,782.00 |
| Dec 31, 2025 | -57,782.00 |
| Sep 30, 2025 | 125,807.00 |
| Sep 30, 2025 | 125,807.00 |
| Jun 30, 2025 | -115,617.00 |
| Jun 30, 2025 | -115,617.00 |
| Mar 31, 2025 | -139,931.00 |
| Mar 31, 2025 | -139,931.00 |
| Dec 31, 2024 | 458,558.00 |
| Dec 31, 2024 | 458,558.00 |
| Sep 30, 2024 | -83,735.00 |
| Sep 30, 2024 | -83,735.00 |
| Jun 30, 2024 | -736,637.00 |
| Jun 30, 2024 | -736,637.00 |
| Mar 31, 2024 | 568,981.00 |
| Mar 31, 2024 | 568,981.00 |
| Dec 31, 2023 | 269,120.00 |
| Dec 31, 2023 | 269,120.00 |